Literature DB >> 11810462

Immunohistochemical localization of mitogen-activated protein kinase (MAPK) family and morphological changes in rat heart after ischemia-reperfusion injury.

Z Naito1, M Kudo, G Xu, R Nishigaki, M Yokoyama, N Yamada, G Asano.   

Abstract

The mitogen-activated protein kinase (MAPK) family is considered to be activated by stress, but the role of the MAPK family is still unknown in cardiac pathology. In the present study, not only the localization of MAPKs such as the extracellular responsive kinase (ERK), c-jun N-terminal kinase (JNK), and p38 MAPK (p38), but also ultrastructural changes were investigated in the ischemia-reperfusion model of Wistar rats. At 5, 10, 30, 60, and 180 min reperfusion after 30 min ischemia by occluding the coronary artery, the expression of these MAPKs was increased in blood vessels and cardiomyocytes by Western blotting and immunohistochemical methods. In addition, after ischemia reperfusion, various ultrastructural changes such as decreased glycogen granules, mitochondrial swelling, and myolysis were observed in the blood vessels and cardiomyocytes. These results suggest that protein kinases may regulate numerous biological processes, including the regulation of contraction and ion transport.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11810462     DOI: 10.1007/s007950070005

Source DB:  PubMed          Journal:  Med Electron Microsc        ISSN: 0918-4287


  2 in total

1.  SPRED2 deficiency may lead to lung ischemia-reperfusion injury via ERK1/2 signaling pathway activation.

Authors:  Masanori Okada; Masaomi Yamane; Sumiharu Yamamoto; Shinji Otani; Kentaroh Miyoshi; Seiichiro Sugimoto; Akihiro Matsukawa; Shinichi Toyooka; Takahiro Oto; Shinichiro Miyoshi
Journal:  Surg Today       Date:  2018-07-18       Impact factor: 2.549

2.  N-n-butyl haloperidol iodide inhibits H2O2-induced Na+/Ca2+-exchanger activation via the Na+/H+ exchanger in rat ventricular myocytes.

Authors:  Yong-Pan Huang; Fen-Fei Gao; Bin Wang; Fu-Chun Zheng; Yan-Mei Zhang; Yi-Cun Chen; Zhan-Qin Huang; Yan-Shan Zheng; Shu-Ping Zhong; Gang-Gang Shi
Journal:  Drug Des Devel Ther       Date:  2014-09-09       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.